MedPath

IRINOTECAN FOR INJECTION

IRINOTECAN FOR INJECTION

Approved
DIN Number

02312409

Drug Class

Human

Market Date

Oct 31, 2008

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02312409
AIG Number0132910001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CE02 IRINOTECAN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IRINOTECAN HYDROCHLORIDEActive
Strength: 20 MG / ML
Monograph: IRINOTECAN HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.